The MoCA test (Montreal Cognitive Assessment) is a 30-point cognitive screening tool used by healthcare professionals to detect mild cognitive impairment and early dementia. It takes approximately 10 minutes to administer, covers 8 cognitive domains, and has been validated in over 100 countries worldwide. Developed by Dr. Ziad Nasreddine in 1996, the MoCA is now the most widely used brief cognitive screening tool globally. This guide explains what the MoCA test measures, how it is scored, what a passing score means, and how to prepare if you or someone you know needs to take the assessment.
The Montreal Cognitive Assessment (MoCA) is a one-page, 30-item cognitive screening instrument developed by Dr. Ziad Nasreddine at the MoCA Clinic & Institute. It screens for mild cognitive impairment (MCI) — a stage of cognitive decline greater than expected for a person's age and education level, but not severe enough to interfere significantly with daily life. MCI is often a precursor to dementia, including Alzheimer's disease.
Who uses the MoCA:
When the MoCA is used: A healthcare provider may administer the MoCA when a patient or their family reports memory problems, confusion, difficulty with daily tasks, or when a routine screening suggests cognitive concern. It is also used to track progression of known cognitive conditions and to evaluate recovery after stroke, traumatic brain injury, or other neurological events.
How it differs from the MMSE: The Mini-Mental State Examination (MMSE) is an older, similar screening tool. Research shows the MoCA is significantly more sensitive to mild cognitive impairment than the MMSE — it detects subtle cognitive changes that the MMSE misses. Most healthcare providers now prefer the MoCA for this reason.
Practice with our MoCA practice test free to understand each task type before your assessment.
Each section of the MoCA test targets specific cognitive abilities. Understanding what each section tests helps you interpret your score and understand which cognitive functions are being evaluated.
Visuospatial/Executive Function (5 points): The Trail Making Task (connect circles alternating numbers and letters), a clock-drawing task (draw a clock set to 11:10), and a cube-copy task. These assess spatial reasoning and planning. Visuospatial tasks are sensitive early markers of cognitive decline.
Naming (3 points): Identify 3 pictures of animals (typically a lion, camel, rhinoceros). Tests object recognition and word retrieval — both often impaired in early dementia.
Memory/Delayed Recall (5 points): The examiner reads 5 words twice. You are asked to recall them at the beginning of the test, then again approximately 5 minutes later. The delayed recall score is 0–5 points. This is one of the most sensitive indicators of memory decline — difficulty with 5-word recall is associated with early Alzheimer's pathology.
Attention (6 points): Includes a forward digit span (repeat 5 digits), backward digit span (repeat 3 digits in reverse), a vigilance task (tap on A), and serial subtraction (count back from 100 by 7s). Tests working memory and sustained attention.
Language (3 points): Repeat 2 complex sentences verbatim, then name as many words as possible starting with the letter F in 1 minute (fluency). Language tasks detect word-finding difficulties and verbal fluency changes.
Abstraction (2 points): Explain how 2 pairs of objects are alike (e.g., train and bicycle, watch and ruler). Tests conceptual reasoning — a higher-order cognitive function often affected in frontal lobe conditions.
Orientation (6 points): Name today's date, month, year, day of week, location, and city. Orientation errors indicate more advanced cognitive impairment.
Use our MoCA Practice Tests to practice each domain and our MoCA test for full-format simulations.
Understanding what MoCA scores mean in clinical context is important for patients, families, and caregivers.
26–30 (Normal range): A score of 26 or higher is considered within normal limits for cognitive functioning. The score is adjusted by 1 point for patients with 12 or fewer years of formal education (so a score of 25 becomes 26 after adjustment). A normal MoCA does not rule out early cognitive changes — it means no significant impairment was detected at this screening level. Repeat testing over time is recommended for patients with subjective memory complaints.
18–25 (Mild cognitive impairment range): Scores in this range warrant further evaluation. Not everyone in this range has MCI — factors like anxiety, depression, pain, medications, and inadequate sleep can all temporarily depress scores. A neuropsychological evaluation provides a comprehensive picture. MCI in this range is associated with increased risk of progression to dementia over 5–10 years, though many individuals with MCI do not progress.
Below 18 (Moderate-to-severe impairment range): Scores below 18 indicate significant cognitive impairment requiring comprehensive evaluation. Scores below 10 are associated with severe dementia. The MoCA cannot diagnose dementia on its own — diagnosis requires clinical history, functional assessment, neuroimaging, and laboratory evaluation. However, a low MoCA score is a strong indicator for specialist referral.